1. Home
  2. GWH vs SNTI Comparison

GWH vs SNTI Comparison

Compare GWH & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ESS Tech Inc.

GWH

ESS Tech Inc.

HOLD

Current Price

$0.86

Market Cap

26.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$1.07

Market Cap

29.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GWH
SNTI
Founded
2011
2016
Country
United States
United States
Employees
62
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.6M
29.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GWH
SNTI
Price
$0.86
$1.07
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$2.25
$8.50
AVG Volume (30 Days)
764.2K
163.7K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.31
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$33.99
N/A
Revenue Next Year
$1,328.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.77
52 Week High
$13.87
$2.88

Technical Indicators

Market Signals
Indicator
GWH
SNTI
Relative Strength Index (RSI) 48.01 57.03
Support Level $0.73 $0.88
Resistance Level $1.15 $1.19
Average True Range (ATR) 0.11 0.06
MACD 0.02 0.01
Stochastic Oscillator 37.47 64.66

Price Performance

Historical Comparison
GWH
SNTI

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. It develops and manufactures long-duration energy storage systems based on iron flow battery technology. The company's batteries use earth-abundant materials, including iron, salt, and water, and are designed for high cycle life and recyclability. It operates as a single business operating segment, which includes all activities related to the design, engineering, and manufacturing of the company's long duration energy storage products. The company's revenue is derived from the sale of its energy storage products and from service contracts.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: